Syndax Pharmaceuticals, Inc.
SNDX
$11.54
$0.494.43%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -11.94% | -23.60% | 5.99% | 0.10% | -41.70% |
| Total Depreciation and Amortization | -100.00% | -33.33% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.30% | 41.33% | 21.93% | 4.13% | 4.33% |
| Change in Net Operating Assets | 115.23% | 225.38% | 38.85% | -163.33% | 1,534.82% |
| Cash from Operations | 7.92% | 13.01% | 14.25% | -102.06% | 7.40% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -409.71% | 40.64% | 162.12% | -510.18% | -140.65% |
| Cash from Investing | -409.71% | 40.64% | 162.12% | -510.18% | -140.65% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 21.79% | 358.28% | -68.82% | -99.16% | 13,864.51% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 11,114.49% | 358.28% | -68.82% | -99.16% | 13,864.51% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -23.74% | 399.63% | 94.90% | -190.01% | 7,470.42% |